B

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Senior Director – Medical Product Lead - Global Medical Cardiovascular

Biology & BiotechConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA

About the Job

Requirements

  • Life sciences and/or healthcare professional training with an advanced degree (MD, PharmD, or PhD) is required.
  • At least 8 years of experience in the pharmaceutical industry in Medical Affairs/Medical Strategy or Clinical Research, with experience in cardiovascular medicine, thrombosis, anticoagulation, stroke, or related therapeutic areas.
  • Deep scientific knowledge of thrombosis biology, anticoagulation, atrial fibrillation, and/or stroke prevention is strongly preferred; experience with factor XI/XIa science is a plus.
  • Ability to interpret complex clinical data and translate insights into global medical strategy, particularly in late-stage development and pre-launch/launch settings.
  • Analytical skills and ability to work effectively with cross-functional teams including clinical, commercialization, regulatory, HEOR, access, and safety.
  • Strategy development, critical thinking, people-management leadership, decision-making, and ability to create and implement short- and long-range worldwide medical plans.
  • Track record of engaging global/international thought leaders and experts in cardiovascular medicine, thrombosis, anticoagulation, and/or stroke prevention, and ability to build and sustain high-impact external scientific relationships.
  • Experience leading worldwide medical affairs programs and working in a global matrixed organization across multiple geographies and cultures.
  • Entrepreneurial thinking, ability to anticipate needs, and ability to assess and manage business and organizational risks in a complex global environment.
  • Organization, motivation, people-management, interpersonal, and communication skills.
  • Familiarity with all phases of drug development, including clinical development, regulatory, and life cycle management in a global context.
  • HQ-based position requiring approximately 20–30% international/domestic travel.

Responsibilities

  • Develop and execute the Worldwide Medical Affairs strategy for Milvexian across priority indications, initially focusing on atrial fibrillation and secondary stroke prevention, aligned with the overall BMS cardiovascular disease area strategy.
  • Serve as the core Worldwide medical representative for Milvexian Program Teams, providing strategic medical and scientific leadership across cross-functional global forums.
  • Lead the cross-functional Asset/Indication Medical Strategy team for Milvexian, setting strategic direction and aligning Worldwide medical deliverables across global markets.
  • Define the Worldwide medical strategy and scientific narrative for Milvexian, incorporating the factor XIa mechanism, emerging anticoagulation science, and the evolving external treatment landscape in atrial fibrillation and secondary stroke prevention.
  • Position Milvexian within the BMS cardiovascular disease area strategy by integrating competitive intelligence, evolving standards of care, and insight generation across thrombosis prevention settings.
  • Provide Worldwide medical leadership for the Milvexian asset, focusing on the Phase 3 LIBREXIA-AF study in atrial fibrillation and Phase 3 LIBREXIA-STROKE study in secondary stroke prevention, and translate clinical milestones into actionable medical strategies.
  • Partner with the US Milvexian Medical Lead and regional/local medical teams to ensure strong coordination.
  • Build effective working relationships with alliance counterparts; participate in joint planning and governance forums to support aligned global medical strategies, coordinated execution, and issue resolution while representing BMS perspectives and strategic interests.
  • Lead workstreams to identify evidence gaps and develop comprehensive Integrated Evidence Plans, including interventional and non-interventional evidence-generation strategies relevant to global atrial fibrillation and secondary stroke prevention populations.
  • Establish and oversee global medical data-generation strategies; collaborate with Medical Evidence Generation to support Investigator Sponsored Research and other Milvexian evidence-generation activities from concept through dissemination.
  • Deliver Worldwide Medical Communications plans for Milvexian, including publications strategy, scientific exchange, symposia, and data dissemination at key cardiovascular and stroke congresses.
  • Engage high-impact global external experts in thrombosis, anticoagulation, atrial fibrillation, stroke neurology, and vascular medicine to identify and translate insights into asset strategy.
  • Partner with Discovery, Clinical Research, Regulatory, Safety, HEOR/Access, Commercial, and alliance-facing teams to ensure the science, clinical profile, and value story of Milvexian are understood and appropriately communicated internally and externally; represent BMS medical priorities in collaboration with Johnson & Johnson.
  • Contribute the Worldwide medical perspective to target product profile evolution, label strategy, evidence priorities, and access-related discussions for Milvexian.
  • Select external organizations and researchers with appropriate expertise in anticoagulation, cardiovascular medicine, and stroke prevention for global research collaborations.
  • Represent BMS scientific leadership in thrombosis prevention and factor XIa science at international scientific meetings, advisory boards, and other external scientific forums.

Desired Qualifications

  • Experience with factor XI/XIa science is a plus.
  • Experience working successfully in alliance or co-development/co-commercialization environments, including leading and influencing across organizational boundaries, navigating shared governance, and balancing collaboration with representation of company interests, is strongly preferred.
  • Launch expertise in cardiovascular therapeutic areas is preferred, ideally including anticoagulation, thrombosis prevention, or stroke-related indications.

About the Company

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Bristol Myers Squibb discovers, develops and sells prescription medicines for serious illnesses, including cancer, blood disorders, immune diseases and heart disease, for patients treated by doctors and hospitals around the world. Its best-known drug is Opdivo, an immunotherapy that helps the body's own immune system find and attack many kinds of cancer. Researchers develop drug candidates in its labs or bring them in through acquisitions and partnerships, then test them in clinical trials to win regulatory approval. The company makes and markets the approved medicines and earns its revenue from sales of patent-protected drugs. Its roots go back to a business founded in 1887, and it is based in Lawrence Township, New Jersey.

Company size
10,001+
Company stage
IPO
Headquarters
Lawrence Township, NJ
Founded
1887

Recently Posted Jobs

Explore more opportunities at Bristol Myers Squibb

See more jobs